Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06550453
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-02
Brief Title:
Safety and Efficacy of Pembrolizumab in Combination With Bevacizumab CapeOX in the Neoadjuvant Treatment of RAS-mutated BRAF Wild-type Microsatellite-stabilized Locally Advanced Colorectal Cancer
Sponsor:
None
Organization:
None
Organization Data
Organization:
None
Class:
None
Study ID:
None
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
None
Lead Sponsor Class:
None
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None